Research Peptide Reconstitution Calculation Worksheet for Canadian Labs

Quick answer: what belongs in a peptide reconstitution calculation worksheet?#

A peptide reconstitution calculation worksheet should record the evidence behind a prepared research solution before that solution is used in a non-clinical experiment. The worksheet should identify the peptide lot, the diluent lot, the certificate or COA, the nominal vial content, the diluent volume, the unit conversion, the resulting stock concentration, the reviewer who checked the arithmetic, the container or aliquot IDs, the storage condition, the required controls, and the final decision: accept, clarify, quarantine, reject, or exclude from a sensitive endpoint.

The worksheet should not be a personal-use calculator. Northern Compound keeps this asset inside the research-use-only boundary. There are no human dosing fields, injection technique instructions, treatment endpoints, athletic-performance protocols, fertility protocols, cosmetic-use instructions, or claims that a peptide produces a clinical outcome. The useful job is narrower: make concentration math and lot traceability auditable.

Use this worksheet beside the peptide reconstitution guide, the bacteriostatic water lot-release checklist, the research peptide solvent compatibility matrix, the research peptide batch documentation template, the research peptide storage SOP, and the aliquot labeling template. Those pages handle adjacent parts of the file. This page focuses on the calculation record that connects material identity, solvent choice, concentration, controls, and release decision.

For supplier-context review, a diluent reference such as Bacteriostatic Water 10 mL should be treated as a documentation path only. Lots change. Labels change. Certificate access changes. A ProductLink can route the reader to the current product record, but the calculation worksheet still has to capture the exact evidence used in the research file.

Download the CSV worksheet#

Use the research peptide reconstitution calculation worksheet CSV when the record needs to move into a spreadsheet, batch folder, shared drive, or procurement review.

The download is intentionally plain. It includes fields for material identity, diluent identity, calculation setup, arithmetic review, preparation record, controls, disposition, and RUO compliance boundary. It does not include administration routes, human-use volumes, personal protocols, dose-per-bodyweight fields, cycle planning, treatment claims, or outcome promises.

A completed worksheet should sit beside the peptide COA, product-page capture, vial-label photo, diluent release record, solvent-compatibility note, storage log, aliquot label record, deviation log, and any supplier response. If a reviewer later asks why a concentration was used, which diluent lot was selected, or why an endpoint did not require a preservative-matched control, the answer should be visible without reconstructing the decision from memory.

Why this worksheet is worth making#

Reconstitution content on the open web is usually too casual. It often jumps from vial size to final volume as if the only problem is arithmetic. In real research documentation, the arithmetic is only one layer. The stronger question is whether the concentration record can survive a later review.

A useful worksheet improves at least seven parts of the file.

First, it links the material identity chain. The peptide lot, COA, supplier page, invoice or order record, vial label, diluent lot, and storage record should all point to the same research material. A concentration value without lot identity is weak evidence.

Second, it makes unit conversion visible. Milligrams, micrograms, nanomoles, micromoles, millilitres, microlitres, and molar concentration units can be mixed carelessly. The worksheet should show the exact formula and units, not just the final number.

Third, it forces a second-person review when the concentration matters. A second reviewer does not make a poor method good, but it catches transcription errors, misplaced decimals, stale vial assumptions, and unit mismatches before they enter the experiment.

Fourth, it treats the diluent as a method variable. Bacteriostatic water, sterile water, buffered saline, dilute acid, carrier protein, DMSO-containing stocks, and other vehicles can have different effects on solubility, stability, contamination assumptions, pH, osmolality, preservative exposure, and assay compatibility. The worksheet should not hide the vehicle behind the word “reconstituted.”

Fifth, it connects the calculation to controls. If the vehicle can move the endpoint, the file may need a vehicle-only control, preservative-matched control, blank, matrix control, or stability-control note. The answer depends on the model and endpoint. The worksheet should create the prompt.

Sixth, it links the prepared stock to storage and aliquot records. Concentration math is incomplete if the prepared material is later split into unlabeled containers, exposed to unknown temperatures, or freeze-thawed without a log. The calculation page should hand off cleanly to storage, labeling, and excursion records.

Seventh, it protects the RUO boundary. A research worksheet should not drift into personal-use guidance. The fields should be written for non-clinical documentation: lot, certificate, formula, concentration, controls, storage, review, and disposition.

The minimum worksheet fields#

A compact worksheet should still include the following fields.

This is not bureaucracy for its own sake. Each field closes a common gap. If a prepared solution later produces an unexpected result, the reviewer can ask whether the issue came from the peptide lot, the solvent, the arithmetic, the storage condition, the container, the assay vehicle, or the endpoint itself.

Copyable reconstitution calculation record#

Use this plain-text version when a quick record is easier than a spreadsheet.

Research peptide reconstitution calculation worksheet

Material identity
Peptide or research material name:
Supplier:
Product page URL:
Product page captured on:
Order or invoice reference:
Peptide lot number:
COA lot number:
Nominal vial content:
COA attached: yes/no
Label photo attached: yes/no

Diluent identity
Diluent name:
Diluent supplier:
Diluent product page URL:
Diluent lot number:
Diluent certificate attached: yes/no/not available
Benzyl alcohol or preservative declared: yes/no/not applicable
Preservative concentration if stated:
Diluent release checklist linked: yes/no
Solvent compatibility reviewed: yes/no

Calculation setup
Calculation purpose:
Intended non-clinical endpoint or file:
Target stock concentration:
Diluent volume added:
Measurement device used:
Formula written in file: yes/no
Second-person check required: yes/no

Arithmetic check
Amount unit conversion:
Volume unit conversion:
Final concentration:
Independent recalculation result:
Reviewer initials:
Review date:
Discrepancy found: yes/no
Discrepancy resolution:

Preparation record
Prepared by:
Date and time prepared:
Container or aliquot ID:
Mixing observation:
Visible particulate, colour, foam, or residue:
Storage condition assigned:
Aliquot label record linked: yes/no/not applicable
Freeze-thaw log created: yes/no/not applicable
Temperature excursion rule captured: yes/no

Controls
Vehicle-only control needed: yes/no/not applicable
Preservative-matched control needed: yes/no/not applicable
Blank or matrix control needed: yes/no/not applicable
Endpoint sensitivity reviewed: yes/no
Control rationale:

Disposition
Decision: accept / clarify / quarantine / reject / exclude from sensitive endpoint
Reason:
Linked records:
Follow-up owner:
Follow-up due date:
Final reviewer/date:

Compliance boundary
RUO-only review completed: yes/no
No human dosing, injection, treatment, bodybuilding, fertility, cosmetic, or personal-use fields included: yes/no
Medical or therapeutic claim removed: yes/no/not applicable

The most important line is the disposition. A calculation worksheet should not force acceptance. It should make uncertainty visible. If the COA does not match, the amount is ambiguous, the diluent lot is undocumented, the formula cannot be checked, or the endpoint is vehicle-sensitive without controls, the correct answer may be clarify or quarantine.

Formula block: keep the arithmetic auditable#

A useful worksheet does not need to turn into an online calculator. It does need to make the calculation reproducible from primary fields. The reviewer should be able to start with the vial record, the diluent record, and the volume field, then arrive at the same concentration without guessing which unit conversion was used.

Use this formula block as a documentation pattern:

The mass-per-volume row is the common one, but the worksheet should not hide a molar or dilution-based assumption. If a peptide is documented by sequence and molecular weight, the file should say whether the concentration was treated as mass-per-volume only or converted into molar units for an assay plan. If a prepared parent stock is diluted again, the child calculation should reference the parent worksheet ID instead of becoming a loose number in a notebook.

A reviewer should check four things before accepting the arithmetic:

1. Source field match. The amount used in the formula matches the vial label, COA note, or documented fill claim. If the label says one thing and the COA says another, the worksheet should pause at clarify or quarantine.
2. Unit path. The conversion path is written. A record that jumps from milligrams and millilitres to micromolar concentration without showing molecular weight is incomplete.
3. Volume basis. The volume is the actual final preparation volume used for the record, not a copied example volume from another lot or guide.
4. Rounding effect. The rounded number is still appropriate for the endpoint. If rounding creates a meaningful difference between lots, keep the unrounded value in the worksheet and define the reporting value separately.

This is where many public calculators are too thin for a research file. They can produce a number, but they rarely preserve the evidence trail: which lot, which label claim, which solvent, which final volume, which unit system, who checked it, and what happened if the number did not match the independent recalculation.

QA review gates for the worksheet#

The worksheet works best when it has gates. A gate is a point where the file either moves forward, pauses for clarification, quarantines the material, or rejects the record format. Without gates, a worksheet becomes a decorative checklist that people complete after the decision has already been made.

Use three review gates.

Gate 1: identity and source evidence#

Before any arithmetic matters, the reviewer should confirm that the material identity chain is coherent. The supplier page, vial label, COA, order record, lot code, nominal amount, and storage language should point to the same research material. A clean formula cannot rescue a worksheet that uses the wrong lot or an ambiguous amount.

The worksheet should pause when:

• the peptide lot number is missing or conflicts with the COA;
• the nominal amount is unclear, overwritten, or copied from a different vial size;
• the product page was not captured and has since changed;
• the COA has no lot identifier or uses a lot code that cannot be mapped to the vial;
• the material name, salt form, blend ratio, or sequence notation is inconsistent across records.

If the issue is a notation problem, attach the peptide sequence notation checklist. If the issue is broader lot release, attach the research peptide lot release checklist. The reconstitution worksheet should not become the place where every identity problem is solved. It should expose the problem and point to the right record.

Gate 2: calculation and reviewer independence#

The second gate checks arithmetic and independence. The person preparing the worksheet should write the source fields and formula. The reviewer should recalculate from those fields, not from the preparer's final answer. That difference matters. A reviewer who checks only whether the final number “looks reasonable” may repeat the original error.

A strong reviewer note says what was checked: amount, volume, unit conversion, formula, final concentration, rounding, parent-child dilution link, and whether the control decision follows the vehicle exposure. It should also say what happened when the recalculation disagreed. The right outcome may be a corrected worksheet, a second preparation, a supplier clarification, an excluded endpoint, or quarantine until the evidence is clean.

Gate 3: handoff to labels, storage, and controls#

The final gate asks whether the prepared stock can be found, interpreted, and reviewed later. The container ID, aliquot labels, storage location, hold-time rationale, freeze-thaw log, excursion rule, and control decision should be linked before the record is treated as released.

This gate catches the common failure where the math is correct but the material becomes untraceable after preparation. If the parent worksheet says one concentration and the child aliquot label says another, the batch file needs a label reconciliation step. If the worksheet says bacteriostatic water was used but the endpoint has no vehicle-control note, the file needs a control rationale. If the prepared material moves to a freezer without a storage record, the concentration value is no longer attached to a defensible handling history.

Worked documentation example: not a dosing example#

The following example is deliberately abstract. It shows how the worksheet should document a concentration record without becoming human-use guidance.

Notice what is missing: injection routes, personal-use volumes, bodyweight calculations, cycle schedules, bodybuilding language, disease-treatment outcomes, cosmetic-use promises, or fertility claims. Those fields do not make the worksheet more useful. They make it less compliant and less linkable.

Spreadsheet implementation notes#

The CSV download is intentionally simple so it can be copied into a spreadsheet, LIMS-style intake form, shared-drive template, or controlled document. If a lab adapts it, keep the following safeguards:

• lock formula cells or use protected columns for reviewer-calculated values;
• keep raw source fields separate from derived values;
• record the formula text, not only the formula output;
• preserve units in separate fields when possible;
• keep drop-down choices for disposition values so “accept,” “clarify,” “quarantine,” “reject,” and “exclude from endpoint” do not fragment into synonyms;
• require linked record IDs for COA, diluent release, aliquot label, storage log, and deviation log;
• avoid any field that asks for human dosing, injection volume, route of administration, bodyweight, cycle length, treatment intent, or personal outcome.

For version control, include a worksheet version, template owner, effective date, and change note. If a formula or required field changes, old records should remain readable. Do not overwrite prior worksheets in a way that destroys the original record. If the correction matters, open a deviation note or CAPA-style follow-up and link it to the revised worksheet.

Unit discipline: where mistakes usually enter#

Most concentration errors are boring. That is why they survive. They come from shorthand, copied formulas, unstated assumptions, or final-number-only records.

Common failure points include:

• confusing milligrams and micrograms;
• treating a labelled peptide amount as exact without reviewing the COA and fill claim;
• recording a final concentration without the formula;
• using mL in one note and uL in another without conversion;
• copying a calculation from a different vial size;
• changing the diluent volume after the first calculation without updating the final concentration;
• assuming every “5 mg vial” has the same preparation record;
• forgetting that aliquot concentration must match the parent stock record;
• failing to note whether the concentration is mass per volume, molar, or activity-based;
• using a prepared stock in an assay without recording the vehicle-control decision.

The worksheet should require both the setup and the check. The first person writes the formula. The second person recalculates from the primary fields. If the two numbers disagree, the record stays unresolved until the discrepancy is explained.

Diluent identity belongs in the calculation#

The diluent line is not optional. A peptide solution record that says only “reconstituted” has already hidden one of the method variables.

For many peptide research files, the diluent may be a simple aqueous vehicle. For others, solubility or endpoint compatibility may require a different solvent, buffer, pH context, carrier protein, or staged preparation. Bacteriostatic water is often discussed because it contains benzyl alcohol preservative, but preservative presence is not a universal advantage. It can be a useful documentation feature in some workflows and an endpoint artefact in others.

The worksheet should ask:

Use the bacteriostatic water lot-release checklist when the diluent itself needs a release record. Use the solvent compatibility matrix when the real question is whether the vehicle makes sense for the material and endpoint.

Control logic: the worksheet should ask, not assume#

A calculation worksheet cannot decide the whole experimental design, but it can prevent a blind spot. The control section should ask whether the vehicle can affect the endpoint and whether the file needs a matching control.

Examples:

The answer might be “not applicable.” That is fine when the rationale is documented. The weak version is silence. A later reader should not have to guess whether the endpoint ignored vehicle effects because they were irrelevant or because nobody asked.

How it fits into the rest of the batch file#

The calculation worksheet is one record in a chain. It should not replace the batch file, storage SOP, receiving record, COA review, or deviation process.

A strong file usually links these records:

1. supplier page capture for the peptide;
2. peptide COA or certificate;
3. vial label photo;
4. receiving inspection note;
5. diluent certificate or lot-release checklist;
6. solvent-compatibility note;
7. reconstitution calculation worksheet;
8. aliquot label record;
9. storage log;
10. freeze-thaw or excursion log if relevant;
11. vehicle-control rationale;
12. final disposition note.

The calculation worksheet is the bridge between procurement evidence and experimental use. It says what material entered the prepared stock, what volume was used, what concentration resulted, who checked the arithmetic, and what unresolved uncertainty remains.

Cap rules: when a worksheet should block release#

Do not average away severe failures. A prepared-solution record can look tidy and still be unreleasable if one critical field fails.

A cap rule does not mean every issue is permanent. It means the worksheet should not pretend the issue is minor. Clarify with the supplier, correct the unit, replace the record, add the control, or quarantine the material until the evidence is adequate.

Example: documentation-only concentration record#

This example is intentionally generic and non-clinical. It is not a protocol.

A lab receives a lyophilized peptide vial for an in-vitro assay file. The COA names the material, lot, purity method, and nominal amount. The analyst captures the supplier product page, photographs the vial label, and confirms the lot number. The planned preparation needs a stock concentration recorded for assay dilution planning. The analyst selects a documented diluent, records the diluent lot, links the diluent release checklist, writes the formula, converts units, and records the final concentration. A second reviewer recalculates the concentration from the amount and volume fields.

The endpoint is vehicle-sensitive, so the worksheet prompts a vehicle-only control and notes whether a preservative-matched control is needed. The stock is assigned a container ID. Aliquot labels carry the material name, lot, concentration, preparation date, storage condition, and parent worksheet ID. Storage and freeze-thaw logs are linked.

The final disposition says “accept” only if the lot evidence, calculation, controls, labels, and storage handoff are complete. If the diluent lot is missing or the formula does not match the reviewer calculation, the disposition changes to clarify or quarantine.

That is the level of detail a reconstitution worksheet should support. It is not glamorous. It is useful.

Reviewer checklist before release#

Use this release checklist after the worksheet is filled out and before the prepared solution is treated as usable in a non-clinical file. It is intentionally stricter than a casual bench note because the reviewer is not only checking whether a number was calculated. The reviewer is checking whether the number can be trusted later.

A release reviewer should be comfortable saying: “I can reconstruct the material, solvent, concentration, control logic, and storage handoff from this file alone.” If the reviewer needs to search email, infer a volume, remember which vial was used, or ask the preparer what a shorthand meant, the worksheet is not ready for accept.

The most common pause decision is clarify. Clarify is appropriate when the issue may be repairable: a missing product-page capture, an ambiguous preservative statement, a rounding note that needs explanation, or a formula that needs to be rewritten with units. Clarify should have an owner and due date. It should not become a permanent holding pattern.

Quarantine is stronger. Use it when the material should not move forward until evidence is corrected: lot mismatch, missing source amount, unresolved reviewer discrepancy, vial damage, contamination concern, or a storage handoff that cannot be reconstructed. Quarantine is not a punishment. It is a way to stop a weak record from contaminating a stronger experiment.

Reject applies when the record format itself has crossed the RUO line or when the evidence is too weak to repair. A worksheet that contains human dosing, administration routes, personal-use fields, bodybuilding cycle language, treatment intent, or cosmetic outcome promises should be rejected as a document, even if some arithmetic inside it is numerically correct. The compliance boundary is part of quality.

Exclude from endpoint is useful when the material may still be documented but should not support a specific readout. For example, a preservative-containing vehicle might be acceptable for one file and inappropriate for a sensitive cell-viability, microbial, inflammatory, mitochondrial, or barrier-integrity endpoint unless controls are added. The worksheet should let the reviewer narrow the release instead of forcing a binary accept/reject decision.

How to adapt the worksheet without weakening it#

Labs and technical buyers will adapt the CSV to their own systems. That is expected. The dangerous part is deleting the fields that make the worksheet auditable.

Keep these fields even in a shorter version:

• material name, supplier, product page capture, lot number, and nominal amount;
• COA or certificate status and any identity-method note;
• diluent name, supplier, lot, preservative/excipient declaration, and release status;
• calculation purpose, source values, units, formula text, and final concentration;
• independent recalculation result, reviewer initials, and discrepancy resolution;
• container or aliquot ID, label record, storage log, freeze-thaw or excursion rule;
• vehicle-control rationale and endpoint sensitivity note;
• disposition, reason, follow-up owner, and final reviewer/date;
• RUO-only compliance boundary.

Fields can be renamed to match a LIMS, ELN, shared spreadsheet, or controlled document. The meaning should not change. “Reviewer note” can become “QA check.” “Disposition” can become “release status.” “Diluent release reviewed” can become “vehicle lot accepted.” The important part is that a later reader can still answer what was prepared, from which lot, in which vehicle, at what concentration, who checked it, where it went, and why it was accepted or held.

Do not add consumer-facing fields. If a stakeholder asks for dose-per-bodyweight, administration route, injection volume, cycle length, treatment goal, cosmetic outcome, or personal protocol fields, that is a signal to split the document. This worksheet is for research-material documentation. It should not be stretched into a human-use planning tool.

FAQ#

References#

• DailyMed. Bacteriostatic Water for Injection, USP description.
• Health Canada. Good manufacturing practices guide for drug products, GUI-0001.
• International Council for Harmonisation. ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
• United States Pharmacopeia. Bacterial Endotoxins harmonisation page.
• FDA. Guidance for Industry: Pyrogen and Endotoxins Testing Questions and Answers.
• OECD. OECD Principles on Good Laboratory Practice.
• ISO. ISO/IEC 17025 testing and calibration laboratories overview.

RUO compliance note#

This article is for research-use-only documentation. It is not medical advice, injection instruction, dosing guidance, treatment guidance, compounding instruction, fertility guidance, cosmetic guidance, athletic-performance advice, or a recommendation for personal use. Researchers are responsible for verifying current supplier records, lot-specific certificates, storage instructions, local requirements, and endpoint-specific controls before any material enters a non-clinical file.